A chapter of The Invisible Fire

The Insulin
Switch.

It's called "the hormone that lowers blood sugar." That's true, and almost completely misleading — the way "a thermostat is the thing that clicks" is true. Insulin is the master switch that decides, thousands of times a day, whether your body stores or burns. And when it fails, it fails quietly — for years, unmeasured. It is the Invisible Fire itself.

Scroll to begin
Not the sugar hormone

The one hormone the whole fire turns on.

Every other chapter of this series meets insulin somewhere — holding salt in the kidneys, freeing the sex hormones, running the liver's fat-making, locking body fat in place. This is the chapter about the hormone itself. Because once you understand what insulin actually does, the scattered conditions of the series stop looking like separate diseases and start looking like what they are: one signal, running high, doing damage in many rooms at once.

In metabolic disease the problem is usually not too little insulin. For years, it's far too much — a signal shouting at cells that have stopped listening.
Before anything else — and this matters more here than anywhere in the series: if you take insulin or a sulfonylurea (or certain other glucose-lowering drugs), the changes in this piece can lower your blood sugar fast. Taken against a dose set for your old, higher need, that can cause dangerously low blood sugar. This is not a reason to avoid improving things — it's a reason to do it with your doctor, who can lower the doses to match. A diet that works quickly is a good problem. Never change these medications on your own.
Question One
What is insulin, really?

Insulin is a small protein — a hormone — made by the beta cells of your pancreas. It's released chiefly in response to rising blood glucose, and to a lesser degree to protein. There's a low background level all the time, and a sharp rise after a meal.

And here's the simple lever at the base of everything that follows: the size of that meal-time rise depends on what you eat. A big dose of fast-absorbed carbohydrate calls for a big insulin release. Fat asks for almost none; protein, some. So what's on the plate sets how hard the beta cells must work — which, over years, turns out to matter enormously.

The master switch

Store, or burn. Insulin sets the mode.

Here's insulin's real job. It's the signal of the fed state — the body's way of announcing "fuel has arrived." When insulin is high, the body switches into store-and-build mode. When it's low, it switches into mobilise-and-burn mode. Almost every major metabolic pathway is wired to that one switch.

Insulin HIGH

Fed · store · build
  • Glucose pulled into muscle and fat
  • Glycogen and fat built; liver makes fat
  • Fat-burning switched off — fat locked in
  • Growth and protein-building promoted

Insulin LOW

Fasted · mobilise · burn
  • Liver releases and makes glucose
  • Stored fat released from fat cells
  • Fat burned; liver makes ketones
  • Repair and recycling favoured
You cannot efficiently burn your own body fat while insulin is high — because high insulin is the signal that says "store, do not burn."

That single line reframes a great deal. If the hormone decides whether you store or burn fat, then the hormone, not simply the calorie, is doing much of the governing. A way of eating that keeps insulin low for longer stretches of the day keeps the body in fat-burning mode for longer. This is the machinery beneath the low-carbohydrate results across this series — and why "what kind of fuel, and how often" can matter as much as "how much."

Insulin has a counterweight. Its mirror-image partner, glucagon, says "release" where insulin says "store." The body's true control dial isn't insulin alone but the ratio of the two — insulin dominant after a meal, glucagon rising between meals and overnight. Metabolic disease is, in large part, that dial stuck in one position.

Question Two
So how does it fail — and why so quietly?

Insulin resistance is what its name says: cells become less responsive to the signal. The doors insulin opens get harder to open. Faced with that, the pancreas does the obvious thing — it makes more insulin, enough to force the doors and keep blood glucose normal. And for a long time, it works.

This is the part almost nobody is told. The earliest and longest phase of metabolic disease isn't high blood sugar. It's high insulin, with normal blood sugar — and it can run for well over a decade before glucose ever crosses the line.[8] The trouble is that the standard test measures glucose. So drag the years forward, and watch the two gauges your body actually runs — the one on your chart, and the one that isn't.

The two gauges — one measured, one not
Drag the years of the modern diet forward. Watch the blood-glucose gauge (the one your doctor checks) stay calm — while the insulin gauge climbs.
glucose
5.0
mmol/L fasting
Normal
what your standard blood test measures
insulin
4
mIU/L fasting
Optimal
almost never measured
Years on the modern dietYear 0

That gap — between the gauge that's watched and the gauge that isn't — is the whole tragedy of how metabolic disease is caught. It's exactly the diagnostic blindness this series keeps meeting: the downstream number is watched while the upstream driver runs unmeasured.

The paradox that explains fatty liver

The liver hears half the message.

If cells simply went deaf to insulin, high insulin would do nothing and the picture would be gentler. The reality is stranger and more damaging: the resistance is selective.[6] In the liver, the pathway by which insulin should say "stop releasing glucose" becomes resistant — so the liver keeps pouring out glucose. But the pathway by which insulin says "make fat" stays fully sensitive, and is now being driven by all that extra insulin.

The liver obeys the half of the order that says "make fat" — while ignoring the half that says "stop the glucose."

The result is the worst of both: high blood glucose and a liver busily turning the excess into fat. That's a direct road to raised triglycerides and to fatty liver disease — since renamed from NAFLD to MASLD, the label itself moving to name the metabolic driver — and it's the same insulin-driven fat-making programme that the cholesterol story runs on. One selective failure, several downstream diseases.

How one hormone reaches everything

The hub the whole series turns on.

Insulin is the connective hormone — the single signal whose disturbance shows up in nearly every chapter. Once you can see it, the map reads as one system:

  • Fatty liver & triglycerides — high insulin runs the liver's fat-making programme, the selective-resistance paradox in action.
  • Blood pressure — insulin tells the kidneys to hold sodium; water follows, pressure rises. The salt rope.
  • Sex hormones & PCOS — high insulin lowers the carrier protein SHBG and drives ovarian androgens: the metabolic root of PCOS — in 2026 officially renamed PMOS, the metabolic root written into the name.
  • Weight — insulin locks fat into storage. The master switch, held on "store."
  • Growth & ageing — chronic high insulin is a chronic growth signal, with consequences beyond metabolism.
  • The Invisible Fire itself — hyperinsulinaemia is the through-line beneath the whole picture.

One signal, running through every chapter. Learn to read it, and the fire stops being a mystery.

Question Three
What turns the signal down?

Because insulin is set largely by how the body is fed, it's one of the more responsive things in metabolism — the hopeful part of the story. The levers aren't exotic:

  • A lower carbohydrate load — the single biggest lever, because the fast-carbohydrate spike is the main thing calling for large insulin.
  • Longer gaps between meals — so insulin can actually fall between them, rather than being topped up all day.
  • Movement, and muscle — active muscle takes up glucose with very little insulin, and more muscle amplifies the effect.
  • Sleep — poor sleep drives the counter-regulatory hormones (including cortisol) that push insulin the wrong way.

None of this is a protocol, and none of it is a promise. It's the set of levers that move the signal — offered so the mechanism is understood. What to do with it, for any individual, sits with them and their doctor.

And this is where that safety rule comes back — because here it can bite. If you take insulin or a sulfonylurea, these levers lower your blood glucose fast. Against a dose set for your old need, that can cause dangerous — occasionally life-threatening — low blood sugar. Improving your diet is the right direction; doing it with your doctor, who lowers the doses to match, is the safe way. A diet that works quickly is solved by adjusting medication down under supervision — never by pressing on regardless, and never by stopping medication on your own.
Where this leaves you

Measure the fire, not just the sugar.

If the earliest and longest phase of metabolic trouble is high insulin with normal glucose, then a test that measures only glucose will miss it — by design. Fasting glucose and HbA1c aren't wrong; they're late. The measures that see the earlier phase look at insulin itself, or at its shadow:

  • Fasting insulin — rarely ordered, but a direct look at whether the signal is running high.
  • HOMA-IR — a simple calculation from fasting glucose and fasting insulin; a standard research tool for decades.[7]
  • The triglyceride-to-HDL ratio — an inexpensive marker on any standard lipid panel that tracks reasonably with insulin resistance, needing no special test ordered.[9]

The point isn't to self-diagnose from a ratio. It's to understand why someone can be told "your blood sugar is fine" for years while the process advances — and to know that better questions exist. Reaven showed forty years ago that insulin resistance clusters with high triglycerides, low HDL and high blood pressure long before diabetes.[3] The cluster was named — and then largely left unmeasured in routine care.

The fire isn't a mystery that arrives with a diagnosis. It's a signal that's been shouting — unheard, and unmeasured — long before anyone thought to look.

Ask your body. Ask what the signal is doing — not just what the sugar says.

Insulin is the signal running through every flame of the one fire. Back to the whole picture: The Invisible Fire.

A final word

One signal, in every room of the house.

Everything else in this series has a place on a map, and insulin is the legend that makes the map readable. The roads describe what the body builds; the minerals are the tools; the conditions are what breaks. Insulin is the signal that runs across all of them — the switch that decides, thousands of times a day, whether the body is a factory in build mode or an engine in burn mode.

The single most consequential fact about it is the one least often said out loud: in metabolic disease the problem is usually too much insulin, for years, while every routine test says the sugar is fine. The good news buried in the same fact is that the signal is responsive — it answers, quite quickly, to how the body is fed and moved and rested. Which is why understanding it is worth the effort, and why acting on it is a conversation to have with a doctor rather than a leap to take alone.

Learn to read the signal, and the fire stops being invisible.

Verified references

[3] Reaven GM (1988). Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 37(12):1595-1607. PMID 3056758. Read →

[6] Brown MS, Goldstein JL (2008). Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 7(2):95-96. PMID 18249166. Read →

[7] Matthews DR et al. (1985). Homeostasis model assessment (HOMA): insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412-419. PMID 3899825. Read →

[8] Tabák AG et al. (2009). Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: the Whitehall II study. Lancet 373(9682):2215-2221. PMID 19515410. (Insulin resistance and high insulin present and rising for over a decade before diagnosis.) Read →

[9] McLaughlin T et al. (2003). Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139(10):802-809. PMID 14623617. (The triglyceride-to-HDL ratio as an accessible surrogate.) Read →

The full reference set — insulin signalling (Saltiel & Kahn; Petersen & Shulman), the counterweight glucagon (Unger & Cherrington), the multi-organ picture (DeFronzo) and the sodium and SHBG links — is in the companion document, The Insulin Switch.